Home ›› 19 Nov 2021 ›› Stock
The shareholders of IBN SINA Pharmaceutical Industry have approved a 47 per cent dividend for the financial year 2020-21.
The approval came at an annual general meeting held virtually on Thursday, said a press release.
IBN SINA Pharmaceutical Chairman Kazi Harun Or Rashid presided over the meeting attended by its Managing Director Prof Dr AK M Sadrul Islam, other directors, statutory auditors, compliance auditors and company secretary.
The pharmaceutical company bagged a handsome profit in FY21 and made a significant contribution to the national exchequers by paying Tk 135 crore as income tax, VAT and other applicable taxes.
As per regulations, the company transferred 5 per cent of the total profit -- Tk 3.57 crore -- to the Workers’ Profit Participation Fund (WPPF).
A good number of shareholders, both male and female were present in the Meeting.
The IBN SINA MD briefed the participants about the company’s overall financial condition and replied to different queries by the shareholders.
The AGM reelected Dr Mohammad Ayub Miah and Prof Col (Retd) Dr Zehad Khan as directors by rotation.
